Skip to main content Accessibility help
×
Home

Management of Treatment Resistant Schizophrenia Unresponsive to Clozapine

  • Thomas R. E. Barnes (a1), Christopher J. B. McEvedy (a1) and Hazel E. Nelson (a1)

Extract

A recent challenge in schizophrenia has been the management of patients who have failed to respond not only to standard therapeutic regimes but also to trials of atypical neuroleptics such as clozapine and risperidone. This article focuses on the further psychological and pharmacological management of such patients.

Copyright

Corresponding author

Professor T. R. E Barnes, Department of Psychiatry, Charing Cross and Westminster Medical School, St Dunstan's Road, London W6 8RP

References

Hide All
Abraham, K. R. & Kulhara, P. (1987) The efficacy of electroconvulsive therapy in the treatment of schizophrenia. British Journal of Psychiatry, 151, 152155.
Arana, G. W., Goff, D. C., Frieman, H., et al (1986) Does carbamazepine induced reduction of plasma haloperidol levels worsen psychotic symptoms? American Journal of Psychiatry, 143, 650651.
Babiker, I. E. (1986) Noncompliance in schizophrenia. Psychiatric Developments, 4, 329337.
Baldessarini, R. J., Kando, J. C. & Centorrino, F. (1995) Hospital use of antipsychotic agents in 1989 and 1993; stable dosing with decreased length of stay. American Journal of Psychiatry, 152, 10381044.
Bebbington, P. E. (1995) The content and context of compliance. International Clinical Psychopharmacology, 9 (Suppl. 5), 4150.
Bowen, J. & Barnes, T. R. E. (1994) The clinical characteristics of schizophrenic patients consenting and not consenting to a placebo-controlled trial. Human Psychopharmacology, 9, 423433.
Brandon, S., Gabriel, A. R. & Impastato, D. J. (1985) Leicester ECT trial: results in schizophrenia. British Journal of Psychiatry, 146, 177183.
Breakey, W. R., Goodell, H., Lorenz, P. C., et al (1974) Hallucinogenic drugs as precipitants of schizophrenia. Pyschological Medicine, 4, 255261.
Bredbacka, P.-E., Paukkala, E., Kinnunen, E., et al (1993) Can severe cardiorespiratory dysregulation induced by clozapine monotherapy be predicted? International Clinical Psychopharmacology, 8, 205206.
Breier, A., Buchanan, R. W., Irish, D., et al (1993) Clozapine treatment of outpatients with schizophrenia: outcome and long-term response patterns. Hospital and Community Psychiatry, 44, 11451149.
Bryois, C. & Ferrero, F. (1993) Clinical observation of 11 patients under clozapine–lithium association. European Psychiatry, 8, 213218.
Buckley, P. F., Thompson, P., Way, L., et al (1994) Substance use among patients with treatment resistant schizophrenia: characteristics and implications for clozapine therapy. American Journal of Psychiatry, 151, 385389.
Carmen, J. S., Bigelow, L. B. & Wyatt, R. J. (1981) Lithium combined with neuroleptics in chronic schizophrenic and schizoaffective patients. Journal of Clinical Psychiatry, 42, 124128.
Carpenter, W. T. Jnr., Kurz, R., Kirkpatrick, H. B., et al (1991) Carbamazepine maintenance treatment in outpatient schizophrenics. Archives of General Psychiatry, 48, 6972.
Centorrino, F., Baldessarini, R. J., Kando, J., et al (1994) Serum concentrations of clozapine and its major metabolites: effects of cotreatment with fluoxetine or valproate. American Journal of Psychiatry, 151, 123125.
Chadwick, P., Birchwood, M. & Trower, P. (1996) Cognitive Therapy in Delusions, Voices and Paranoia. Chichester: Wiley.
Chouinard, G. (1988) The use of benzodiazepines in the treatment of manic depressive illness. Canadian Journal of Psychiatry, 49 (November supplement), 1520.
Collins, P. J., Larkin, E. P. & Schubsachs, A. P. W. (1991) Lithium carbonate in chronic schizophrenia – a brief trial of lithium carbonate added to neuroleptics for treatment of resistant schizophrenic patients. Acta Psychiatrica Scandinavica, 84, 150154.
Copp, P. J., Lament, R. & Tennent, T. G. (1991) Amitriptyline in clozapine-induced sialorrhoea. British Journal of Psychiatry, 159, 166.
Csernansky, J. G., Riney, S. J., Lombroso, L., et al (1988) Double-blind comparison of alprazolam, diazepam and placebo for the treatment of negative schizophrenic symptoms. Archives of General Psychiatry, 45, 655659.
Devinsky, O., Honigfeld, G. & Patin, J. (1991) Clozapine-related seizures. Neurology, 41, 369371.
Duke, P., Pantelis, C. & Barnes, T. R. E. (1991) South Westminster Schizophrenia Survey: substance abuse and its relationship to symptomatology (Abstract). Biological Psychiatry, 29 (Suppl.), 664.
Duke, P., Pantelis, C. & Barnes, T. R. E. (1994) South Westminster Schizophrenia Survey. II. Alcohol use in schizophrenia: symptomatology, relationship with tardive dyskinesia, akathisia and age at onset. British Journal of Psychiatry, 164, 630636.
Fink, M. (1979) Convulsive Therapy; Theory and Practice. New York: Raven Press.
Fink, M. (1990) Clozapine and electroconvulsive therapy. Archives of General Psychiatry, 47, 290291.
Fitton, A. & Benfield, P. (1993) Clozapine: an appraisal of its pharmacoeconomic benefits in the treatment of schizophrenia. PharmacoEconomics, 4, 131156.
Fowler, D., Garety, P. & Kuipers, L. (1995) Cognitive Behaviour Therapy for Psychosis. Chichester: John Wiley.
Friedel, R. O. (1986) The combined use of neuroleptics and ECT in drug resistant schizophrenic patients. Psychopharmacology Bulletin, 22, 928930.
Green, A. I., Zalma, A., Berman, I., et al (1994) Clozapine following ECT: a two step treatment. Journal of Clinical Psychiatry, 55, 388390.
Grabowski, J. (1992) Clonidine treatment of clozapine-induced hypersalivation. Journal of Psychopharmacology, 12, 6970.
Grohmann, R., Ruther, E., Sassim, N., et al (1989) Adverse effects of clozapine. Psychopharmacology, 99, S101S104.
Growe, G. A., Crayton, J. W., Klass, D. B., et al (1979) Lithium in chronic schizophrenia. American Journal of Psychiatry, 136, 454455.
Gujavarty, K., Greenberg, L. B. & Fink, M. (1987) Electroconvulsive therapy and neuroleptic medication in therapy-resistant positive symptom psychosis. Convulsive Therapy, 3, 185195.
Haddock, G. & Slade, P. D. (eds) (1996) Cognitive–Behavioural Interventions with Psychotic Disorders. London: Routledge.
Hirsch, S. R., Jolley, A. & Barnes, T. R. E. (1990) Are depressive symptoms part of the schizophrenic syndrome? In Depression in Schizophrenia (ed. DeLisi, L. E.), pp. 2537. Washington: American Psychiatric Press.
Janakiramaiah, N., Channabasavanna, S. M. & Narashima Murthy, N. S. (1982) ECT/chlorpromazine combination versus chlorpromazine alone in acutely schizophrenic patients. Acta Psychiatrica Scandinavica, 66, 464470.
Jann, M. W., Fidoen, G. S., Hernandez, J. M., et al (1989) Clinical implications of increased antipsychotic plasma concentrations upon anticonvulsant cessation. Psychiatry Research, 28, 153159.
Johns, C. A. & Thompson, J. W. (1995) Adjunctive treatments in schizophrenia: pharmacotherapies and electroconvulsive therapy. Schizophrenia Bulletin, 21, 607619.
Johnson, G. G., Littrell, K. H. & Magill, A. M. H. (1994) Starting patients on clozapine in a partial hospitalisation programme. Hospital and Community Psychiatry, 43, 264268.
Johnstone, E. C., Frith, C. D., Crow, T. J., et al (1988) The Northwick Park “functional” psychosis study: diagnosis and treatment response. Lancet, 2, 119125.
Kahn, E. M., Schulz, S. C., Perel, J. M., et al (1990) Change in haloperidol level due to carbamazepine – a complicating factor in combined medication for schizophrenia. Journal of Clinical Psychopharmacology, 10, 5457.
Kando, J. C., Tohen, M., Castillo, J., et al (1994) Concurrent use of clozapine and valproate in affective and psychotic disorders. Journal of Clinical Psychiatry, 55, 255257.
Kibel, D. A., Laffont, I. & Liddle, P. F. (1993) The composition of the negative syndrome of chronic schizophrenia. British Journal of Psychiatry, 162, 744750.
Kingdon, D. G. & Turkington, D. (1994) Cognitive Behavioural Therapy of Schizophrenia. Hove: Lawrence Erlbaum.
Klein, E., Beutal, E., Lerer, B., et al (1984) Carbamazepine and haloperidol versus placebo and haloperidol in excited psychosis: a controlled study. Archives of General Psychiatry, 41, 165170.
Koreen, A. R., Siris, S. G., Chakos, M., et al (1993) Depression in first-episode schizophrenia. American Journal of Psychiatry, 150, 16431648.
Kramer, B. A. (1990) Maintenance electroconvulsive therapy in clinical practice. Convulsive Therapy, 6, 279286.
Lerner, Y., Mintzer, Y. & Schestatzky, M. (1988) Lithium combined with haloperidol in schizophrenic patients. British Journal of Psychiatry, 153, 359362.
Lingjaerde, O., Engstrand, E., Ellingsen, P., et al (1979) Antipsychotic effect of diazepam when given in addition to neuroleptics in chronic psychotic patients; a double-blind clinical trial. Current Therapeutic Research, 26, 505514.
Linszen, D. H., Dingemans, P. M. & Lenior, M. E. (1994) Cannabis abuse and the course of recent onset of schizophrenic disorders. Archives of General Psychiatry, 51, 273279.
Maletzky, B. M. (1973) The episodic dyscontrol syndrome. Diseases of the Nervous System, 34, 178185.
Mann, J. J. (1986) How medication compliance affects outcome. Psychiatric Annals, 16, 567570.
Meltzer, H. Y. (1992) Treatment of the neuroleptic non-responsive schizophrenic. Schizophrenia Bulletin, 18, 515533.
Miller, D. D. (1991) Effect of phenytoin on plasma clozapine concentrations in two patients. Journal of Clinical Psychiatry, 52, 2335.
Milstein, V., Small, J. G., Miller, M. J., et al (1990) Mechanism of action of ECT: schizophrenia and schizoaffective disorder. Biological Psychiatry, 27, 12811299.
Mulvey, E. P. (1994) Assessing the evidence of a link between mental illness and violence. Hospital and Community Psychiatry, 45, 663668.
Negrete, J. C., Knapp, W. P., Douglas, D. E., et al (1986) Cannabis affects the severity of schizophrenic symptoms: results of a clinical survey. Psychological Medicine, 16, 515520.
Nelson, H. E. (1995) Cognitive-behavioural therapy with delusions. Clinical Psychology Forum, 85, 2123.
Nelson, H. E., Thrasher, S. & Barnes, T. R. E. (1991) Practical ways of alleviating auditory hallucinations. British Medical Journal, 302, 327.
Nestoros, J. N., Nair, N. P. V., Pulman, J. R., et al (1983) High doses of diazepam improve neuroleptic resistant chronic schizophrenic patients. Psychopathology, 81, 4247.
Pacia, S. V. & Devinsky, O. (1994) Clozapine-related seizures: experience with 5629 patients. Neurology, 44, 22472249.
Pecknold, J. C. (1993) Survey of the adjuvant use of benzodiazepines for treating outpatients with schizophrenia. Journal of Psychiatry and Neuroscience, 18, 8284.
Perry, P. J., Miller, D. D., Arndt, S. V., et al (1991) Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients. American Journal of Psychiatry, 148, 231235.
Potkin, S. G., Bera, R., Gulasekeram, B., et al (1994) Plasma clozapine concentrations predict clinical response in treatment-resistant schizophrenia. Journal of Clinical Psychiatry, 55 (Suppl. 9), 133136.
Povlsen, U. J., Noring, U., Fog, R., et al (1985) Tolerability and therapeutic effect of clozapine. Acta Psychiatrica Scandinavica, 71, 176185.
Safferman, A. Z. & Munne, R. (1992) Combining clozapine with ECT. Convulsive Therapy, 8, 141143.
Salzman, C., (1980) The use of ECT in the treatment of schizophrenia. American Journal of Psychiatry, 137, 10321041.
Sajatovic, M. & Meltzer, H. Y. (1993) The effect of short-term electroconvulsive treatment plus neuroleptics in treatment-resistant schizophrenia and schizoaffective disorder. Convulsive Therapy, 9, 167175.
Sassim, N. & Grohmann, R. (1988) Adverse drug reactions with clozapine and simultaneous application of benzodiazepines. Pharmacopsychiatry, 21, 306307.
Schneier, F. R. & Siris, S. G. (1987) A review of psychoactive substance use and abuse in schizophrenia: patterns of drug choice. Journal of Nervous and Mental Disease, 175, 641652.
Schulz, S. C., Kahn, E. M., Baker, R. W., et al (1990) Lithium and carbamazepine augmentation in treatment-refractory schizophrenia. In The Neuroleptic Nonresponsive Patient: Characterisation and Treatment (eds Angrist, B. & Schulz, S. C.), pp. 109136. American Psychaitric Press.
Siris, S. G. (1993) Adjunctive medication in the maintenance treatment of schizophrenia and its conceptual implications. British Journal of Psychiatry, 163 (Suppl. 22), 6678.
Siris, S. G., Adan, F., Cohen, M., et al (1988) Post-psychotic depression and negative symptoms: an investigation of syndromal overlap. American Journal of Psychiatry, 145, 15321537.
Siris, S. G., Bermanzohn, P. C., Mason, S. E., et al (1991) Antidepressant for substance-abusing schizophrenic patients: a mini review. Progress in Neuroscience, Psychopharmacology, and Biological Psychiatry, 15, 113.
Siris, S. G., Bermanzohn, P. C., Mason, S. E., et al (1994) Maintenance imipramine therapy for secondary depression in schizophrenia: a controlled trial. Archives of General Psychiatry, 51, 109115.
Small, J. G., Kellams, J. J., Milstein, V., et al (1975) A placebo-controlled study of lithium combined with neuroleptics in chronic schizophrenic patients. American Journal of Psychiatry, 132, 13151317.
Smith, J. & Hucker, S. (1994) Schizophrenia and substance abuse. British Journal of Psychiatry, 165, 1321.
Sramek, J., Herrera, J., Costa, J., et al (1988) A carbamazepine trial in chronic treatment-refractory schizophrenia. American Journal of Psychiatry, 145, 748750.
Stevens, J. R., Bigelow, L., Denney, D., et al (1979) Telemetered EEG–EOG during psychotic behaviours of schizophrenia. Archives of General Psychiatry, 36, 251269.
Stone, J. L., McDaniel, K. D., Hughes, J. R., et al (1986) Episodic dyscontrol disorder and paroxysmal EEG abnormalities: successful treatment with carbamazepine. Biological Psychiatry, 21, 208212.
Taylor, P. J. & Fleminger, J. J. (1980) ECT for schizophrenia. Lancet, i, 13801382.
Toth, P. & Frankenburg, F. R. (1994) Clozapine and seizures: a review. Canadian Journal of Psychiatry, 39, 236238.
Tsuang, M. T., Perkins, K. & Kronfol, Z. (1982) Subtypes of drug abuse with psychosis: demographic characteristics, clinical features and family history. Archives of General Psychiatry, 39, 141147.
Van Kammen, D. P., Docherty, J. P., Marder, S. R., et al (1985) Lithium attenuates the activation-euphoria but not the psychosis induced by d-amphetamine in schizophrenia. Psychopharmacology, 87, 111115.
Warner, J. P., Harvey, C. A. & Barnes, T. R. E. (1994) Clozapine and urinary incontinence. International Clinical Psychopharmacology, 9, 207209.
Welch, J., Manschrek, T. & Redmond, D. (1994) Clozapine induced seizures and EEG changes. Journal of Neuropsychiatry and Clinical Neuroscience, 6, 250256.
Wetterling, T. (1987) Open clinical trial of carbamazepine in chronic schizophrenic inpatients. Pharmacopsychiatry, 20, 127130.
Wilson, W. H. (1992) Clinical review of clozapine in a state hospital. Hospital and Community Psychiatry, 43, 700703.
Wilson, W. H. (1993) Addition of lithium to haloperidol in non-affective, antipsychotic, non-responsive schizophrenia: a double blind, placebo controlled, parallel design clinical trial. Psychopharmacology, 111, 359366.
Wolkowitz, O. M., Breier, A., Doran, A., et al (1988) Alprazolam augmentation of the antipsychotic effects of fluphenazine in schizophrenic patients. Preliminary results. Archives of General Psychiatry, 45, 664671.
Wolkowitz, O. M., Rapaport, M. H. & Pickar, D. (1990) Benzodiazepine augmentation of neuroleptics. In The Neuroleptic-Nonresponsive Patient: Characterisation and Treatment (eds Angrist, B. & Schulz, S. C.), pp. 89108. American Psychiatric Press.
Wolkowitz, O. M. & Pickar, D. (1991) Benzodiazepines in the treatment of schizophrenia: a review and reappraisal. American Journal of Psychiatry, 148, 714726.
Wolkowitz, O. M., Turetsky, N., Reus, V. I., et al (1992) Benzodiazepine augmentation of neuroleptics in treatment-resistant schizophrenia. Psychopharmacology Bulletin, 28, 291295.

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Management of Treatment Resistant Schizophrenia Unresponsive to Clozapine

  • Thomas R. E. Barnes (a1), Christopher J. B. McEvedy (a1) and Hazel E. Nelson (a1)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *